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American Public Health Association honors
Peace
DECEMBER 7, 2007

The American Public Health Association recently presented one of three Statistics Section Awards to
Karl E. Peace, professor of biostatistics in Georgia Southern University’s Jiann-Ping Hsu College of
Public Health, at its annual meeting in Washington, D.C. The award was presented to Peace by
David Williamson, a Georgia Southern University alumnus and Director of the Agency for Toxic
Substances and Disease Registry (ATSDR) in the CDC’s- Division of Health Studies.
‘I accepted this award on behalf of the Jiann-Ping Hsu College of Public Health and Georgia
Southern University with a lot of pride,” Peace said. ‘I believe this recognition will benefit us as we
progress toward national accreditation.”
The award was presented to Peace for his biostatistical contributions to drug research and
development. Peace made pivotal contributions to the development and approval of Tacrine, the
first drug approved for the treatment of Alzheimer’s disease; Gemfibrozil, the first drug approved for
the reduction of Coronary Heart Disease (CHD) risk; and Cytotec, the first drug approved for the
prevention of NSAID induced gastric ulceration.
More than 100 people attended the presentation, including Peace’s son and daughter-in-law, his
colleagues Charles Hardy, dean of the Jiann-Ping Hsu College of Public Health, and Stuart Tedders,
director of the Center for Rural Health and Research. Doctoral student Kelley Chester also attended
the APHA meeting and the presentation.
Following a first career in university teaching, Peace established his second career in research,
technical support and management in the pharmaceutical industry. He held leadership positions at
Burroughs-Wellcome, A.H. Robins, SmithKline and French, G.D. Searle, and Warner Lambert/ParkeDavis. He founded Biopharmaceutical Research Consultants, Inc. (BRCI), a contract research
organization providing a full line of services for the research and development of pharmaceutical
compounds, focusing on the conduct of clinical (trial) investigations. In addition to making pivotal
contributions in the development and approval of drugs to treat Alzheimer’s disease, to reduce the
risk of myocardial infarction, and to prevent and treat gastrointestinal ulcers, Peace also made key
contributions to the development and approval of several drugs to treat anxiety, depression, panic
attacks, hypertension, stroke, cancer, arthritis, and infections.
Following his career in the pharmaceutical industry, Peace returned to academe and helped lay the
groundwork for the Jiann-Ping Hsu College of Public Health, which is named for Peace’s late wife, an
internationally recognized statistics scholar. He is also the founding director of the Karl E. Peace
Center for Biostatistics.

